Compare HUT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUT | PEN |
|---|---|---|
| Founded | 2011 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 12.8B |
| IPO Year | 2023 | 2015 |
| Metric | HUT | PEN |
|---|---|---|
| Price | $120.67 | $316.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 16 |
| Target Price | $65.20 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 3.7M | 365.2K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 0.82 |
| Revenue | $235,118,000.00 | ★ $1,403,665,000.00 |
| Revenue This Year | $161.69 | $14.34 |
| Revenue Next Year | N/A | $13.71 |
| P/E Ratio | ★ N/A | $387.39 |
| Revenue Growth | ★ 44.79 | 17.50 |
| 52 Week Low | $17.87 | $221.26 |
| 52 Week High | $140.80 | $362.41 |
| Indicator | HUT | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 39.31 |
| Support Level | $39.84 | $302.19 |
| Resistance Level | $140.80 | $322.24 |
| Average True Range (ATR) | 10.50 | 2.36 |
| MACD | -1.43 | 0.10 |
| Stochastic Oscillator | 65.55 | 24.67 |
Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.